DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Executes the first project for developing and manufacturing a novel anticancer mAb
Development services for gene and cell therapies is planned to begin first in 2025
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Increased capability to produce medicines for challenging diseases including cancer
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
Subscribe To Our Newsletter & Stay Updated
